In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

What they all have in common is that they are delivered directly into a tumor to help the immune system recognize and attack the malignancy and then, ideally, other cancer cells that ... in response ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell ca ...

Cancer vaccines have been a dream for nearly as long ... She's also trying the same approach in women diagnosed with ductal ...

Through an upcoming clinical trial, about 50 women like Kitay will receive the vaccine, which is the first of its kind to be used for the cancer known as ductal carcinoma in situ, or DCIS ...